UNLOCKING PRECISION IN DERMATOLOGICAL CARE
The SRT-100 is a state-of-the-art superficial radiotherapy system designed to provide non-invasive treatment for various dermatological conditions, including basal cell carcinoma, squamous cell carcinoma, and keloids. This advanced medical device delivers targeted radiotherapy directly to the skin’s surface, effectively eliminating cancerous cells while preserving surrounding healthy tissue. The SRT-100 offers a safe, painless, and cosmetically favorable alternative to traditional surgical procedures, making it an ideal choice for patients seeking minimally invasive treatment options.
The SRT-100 delivers precise doses of radiotherapy directly to the affected area, minimizing damage to surrounding healthy tissue.
Patients undergoing treatment with the SRT-100 experience no incisions, anesthesia, or surgical scarring, resulting in minimal discomfort and faster recovery times.
With the SRT-100, patients can achieve excellent cosmetic outcomes, with minimal to no scarring compared to traditional surgical procedures.
Treatment sessions are performed in an outpatient setting, allowing patients to return to their daily activities immediately following treatment.
The SRT-100 has demonstrated high non-recurrence rates for various dermatological conditions, providing patients with effective treatment options and peace of mind.
During a treatment session with the SRT-100, patients lie comfortably on a treatment table while the device delivers targeted radiotherapy to the affected area. The treatment is painless and typically lasts only a few minutes. Patients may require multiple treatment sessions depending on the severity and location of the condition being treated. Throughout the treatment process, patients are closely monitored by a qualified medical team to ensure optimal results.
With its precise delivery of radiotherapy and excellent cosmetic outcomes, the SRT-100 is changing the landscape of skin cancer treatment and improving the quality of life for patients worldwide.
